Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × Methotrexate × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Burkitt Lymphoma 15 Leukemia, Biphenotypic, Acute 9 Leukemia, Myeloid, Acute 8 Myelodysplastic Syndromes 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Medulloblastoma 4 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Osteosarcoma 3 Neoplasm Metastasis 3 Lymphoma 3 Leukemia 3 Urinary Bladder Neoplasms 2 Recurrence 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myeloid, Accelerated Phase 2 Graft vs Host Disease 2 Blast Crisis 2 Squamous Cell Carcinoma of Head and Neck 1 Shwachman-Diamond Syndrome 1 Sarcoma, Ewing 1 Rhabdoid Tumor 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Primary Myelofibrosis 1 Philadelphia Chromosome 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1

Interventions

pegaspargase 3 tislelizumab 1 sugemalimab 1 relatlimab 1 gemcitabine-oxaliplatin regimen 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Polymerase Chain Reaction 1 Oxaliplatin 1 Nivolumab 1 Immune Checkpoint Inhibitors 1 Ice 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Cholecalciferol 1 Azacitidine 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡